Abstract
The pandemic of coronavirus disease 2019 (COVID-19) has become a threat to human life and society. Scientists and clinicians are struggling with the intrusive SARS-CoV-2 virus to enhance their knowledge about its pathogenesis and find an effective medicine and vaccine to combat its complications. Till now, they have learned that this SARS-CoV-2 has not infected all people exposed to this virus, and also severe respiratory illnesses have not been observed in all infected patients. Patients over 65 or with underlying diseases are more vulnerable to develop severe disease. Based on this premise, a highly challenging question is why some people are more susceptible to this virus and others are not. The present study was aimed to review the current information, which explains the broad spectrum of COVID-19 presentation. Here, we discussed how genetic background, immune system, underlying disease, smoking status, as well as age, race, and gender affect COVID-19 susceptibility.
Keywords: COVID-19, SARS-CoV-2, Age, Race, Gender, Smoking status, Genetic susceptibility, Immune system, Underlying diseases.
Current Molecular Medicine
Title:Do Genetic Factors Predispose People to COVID-19: A Review Article
Volume: 21 Issue: 6
Author(s): Ava Nasrolahi, Karimeh Haghani, Ali Gheysarzadeh and Salar Bakhtiyari*
Affiliation:
- Department of Clinical Biochemistry, School of Medicine, Ilam University of Medical Sciences, Ilam,Iran
Keywords: COVID-19, SARS-CoV-2, Age, Race, Gender, Smoking status, Genetic susceptibility, Immune system, Underlying diseases.
Abstract: The pandemic of coronavirus disease 2019 (COVID-19) has become a threat to human life and society. Scientists and clinicians are struggling with the intrusive SARS-CoV-2 virus to enhance their knowledge about its pathogenesis and find an effective medicine and vaccine to combat its complications. Till now, they have learned that this SARS-CoV-2 has not infected all people exposed to this virus, and also severe respiratory illnesses have not been observed in all infected patients. Patients over 65 or with underlying diseases are more vulnerable to develop severe disease. Based on this premise, a highly challenging question is why some people are more susceptible to this virus and others are not. The present study was aimed to review the current information, which explains the broad spectrum of COVID-19 presentation. Here, we discussed how genetic background, immune system, underlying disease, smoking status, as well as age, race, and gender affect COVID-19 susceptibility.
Export Options
About this article
Cite this article as:
Nasrolahi Ava , Haghani Karimeh , Gheysarzadeh Ali and Bakhtiyari Salar *, Do Genetic Factors Predispose People to COVID-19: A Review Article, Current Molecular Medicine 2021; 21 (6) . https://dx.doi.org/10.2174/1566524020999201113102145
DOI https://dx.doi.org/10.2174/1566524020999201113102145 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tocilizumab: From Rheumatic Diseases to COVID-19
Current Pharmaceutical Design A Mechanistic Review on Plant-derived Natural Inhibitors of Human Coronaviruses with Emphasis on SARS-COV-1 and SARS-COV-2
Current Drug Targets Potential Immunotherapy against SARS-CoV-2: Strategy and Status
Coronaviruses An Updated Review on COVID-19
Infectious Disorders - Drug Targets Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients
Current Pharmaceutical Design Impact of COVID-19 Infection on Maternal and Neonatal Outcomes: A Review of 11078 Pregnancies Reported in the Literature
Current Women`s Health Reviews Advancements in Adjuvanticity of Bioactive Inorganic and Organic Compounds
Endocrine, Metabolic & Immune Disorders - Drug Targets The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking
Combinatorial Chemistry & High Throughput Screening <i>Nigella Sativa</i>: An Immunity Booster as Pandemic Treatment Solution Against SARS-CoV-2
Coronaviruses Overview of Covid-19 Regarding the Cardiovascular Situation in the Light of Current Reports
Cardiovascular & Hematological Disorders-Drug Targets COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases
Current Rheumatology Reviews Hepatic Involvement as Hyperbilirubinemia in Patients with COVID-19: Case Series from Iran
Infectious Disorders - Drug Targets Synthetic and Semi-synthetic Drugs as a Promising Therapeutic Option for the Treatment of COVID-19
Mini-Reviews in Medicinal Chemistry Phytochemical Informatics and Virtual Screening of Herbs Used in Chinese Medicine
Current Pharmaceutical Design Severe Acute Respiratory Syndrome Coronavirus 2 is Penetrating to Dementia Research
Current Neurovascular Research Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Nature of Protein Domain Evolution: Shaping the Interaction Network
Current Genomics Structural Genomics and Drug Discovery for Infectious Diseases
Infectious Disorders - Drug Targets Repurposing Ruxolitinib in Combating COVID-19: A Mini-review
New Emirates Medical Journal A Brief Outlook on Possible Available Solutions, Therapies and Suggestions for COVID-19
Coronaviruses